Clinical Trials
40
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials
A Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab for Treatment-naive Brain Metastases From NSCLC (Non-small Cell Lung Cancer)
- Conditions
- Lung CancerNon Small Cell Lung CancerBrain Metastases
- Interventions
- First Posted Date
- 2025-02-12
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- Latin American Cooperative Oncology Group
- Target Recruit Count
- 46
- Registration Number
- NCT06822543
Race Impact on Efficacy of Niraparib Plus Abiraterone Acetate and Prednisone in Patients With Homologous Repair Deficient Castration-resistant Prostate Cancer
- Conditions
- Prostate CancerHomologous Recombination DeficiencyCastrate Resistant Prostate Cancer
- Interventions
- Drug: Niraparib/Abirate rone acetate fixed-dose combination
- First Posted Date
- 2024-07-30
- Last Posted Date
- 2025-02-14
- Lead Sponsor
- Latin American Cooperative Oncology Group
- Target Recruit Count
- 70
- Registration Number
- NCT06527690
Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian Cohort
- Conditions
- Carcinoma, Adrenocortical RecurrentCarcinoma Adrenal
- First Posted Date
- 2024-02-28
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- Latin American Cooperative Oncology Group
- Target Recruit Count
- 150
- Registration Number
- NCT06279442
- Locations
- 🇧🇷
Pronutrir - Suporte Nutricional e Quimioterapia, Fortaleza, Ceará, Brazil
🇧🇷Hospital do Câncer do Maranhão Dr. Tarquínio Lopes Filho, São Luis, Maranhão, Brazil
🇧🇷Hospital Erasto Gaertner, Curitiba, Paraná, Brazil
Classifying for HER2 Dependence to De-Escalate Neoadjuvant Chemotherapy in Patients With HER2+ Early Breast Cancer Undergoing HER2 Double-Blockade
- First Posted Date
- 2023-10-05
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Latin American Cooperative Oncology Group
- Target Recruit Count
- 63
- Registration Number
- NCT06068985
- Locations
- 🇧🇷
NOB - Núcleo de Oncologia da Bahia (Oncoclínicas), Salvador, Bahia, Brazil
🇧🇷Oncocentro de Minas Gerais (Oncoclínicas), Belo Horizonte, Minas Gerais, Brazil
🇧🇷CPO - Centro de Pesquisa em Oncologia do Hospital São Lucas da PUCRS, Porto Alegre, Rio Grande Do Sul, Brazil
Molecular Characterization of Penile Cancers in Developing Countries
- Conditions
- Penile Squamous Cell Carcinoma
- First Posted Date
- 2023-10-05
- Last Posted Date
- 2023-10-05
- Lead Sponsor
- Latin American Cooperative Oncology Group
- Target Recruit Count
- 24
- Registration Number
- NCT06068998
- Locations
- 🇧🇷
Oncocentro Ceará, Fortaleza, Ceará, Brazil
🇧🇷Hospital Universitário da Universidade Federal do Maranhão (UFMA), São Luís, Maranhão, Brazil
🇧🇷Centro de Pesquisa em Oncologia do Hospital São Lucas da PUCRS, Porto Alegre, Rio Grande Do Sul, Brazil
- Prev
- 1
- 2
- 3
- 4
- 5
- 8
- Next